Afreximbank and Med Aditus signed an agreement to finance the preparation of feasibility studies for a US$40 million pharmaceutical manufacturing plant in Kisumu, Kenya, focusing on essential medicines for various diseases. The state-of-the-art plant will utilize blockchain technology to enhance quality and access to affordable medicines, supporting local production and reducing counterfeit drugs. This initiative is part of Afreximbank’s Africa Health Security Investment Plan and aims to strengthen health security and promote economic development in Africa.
Full Article